Min-Hee Ryu

26PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 09, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|Jun 01, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

|Apr 06, 2026
Predictive Value of Insertion/Deletion Rate in Patients With Gastric Cancer Treated With Nivolumab Plus Chemotherapy.

Hyung-Don Kim, Hyungeun Lee, Sun Young Lee

|Apr 06, 2026
Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification.

In Hye Song, Soomin Ahn, Hyung-Don Kim

|Jan 28, 2026
Association between the presence of malignant ascites and survival outcomes in gastric cancer patients treated with nivolumab plus chemotherapy.

Yuna Lee, Hyung-Don Kim, Hyungeun Lee

|Jan 10, 2026
Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence.

Young Jae Kim, Hyung-Don Kim, Jaewon Hyung

Pageof 5

Frequent Collaborators

9 joint publications

Hyung-Don Kim

4 joint publications

Changhoon Yoo

4 joint publications

Young Soo Park

3 joint publications

Sun Young Rha